Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Jul;101(1):55–59. doi: 10.1111/j.1365-2249.1995.tb02276.x

No evidence for an independent role of anti-heparan sulphate reactivity apart from anti-DNA in lupus nephritis.

M N Hylkema 1, I V Zwet 1, C Kramers 1, M C Van Bruggen 1, A J Swaak 1, J H Berden 1, R J Smeenk 1
PMCID: PMC1553282  PMID: 7621592

Abstract

The presence of anti-heparan sulphate (HS) reactivity in serum is closely related to the occurrence of nephritis in patients with systemic lupus erythematosus (SLE). Since patients with lupus nephritis in general also have high titres of anti-DNA antibodies, we wanted to clarify the relationship between anti-HS and anti-DNA reactivity in serum. Therefore, we studied longitudinally six patients with lupus nephritis who experienced 12 exacerbations of their disease, and five SLE patients without nephritis experiencing 10 periods of non-renal disease exacerbations. In addition, we tested single serum samples of another 24 patients obtained during a renal disease exacerbation and 22 sera of patients without nephritis. The sera of all patients were tested for anti-DNA (Farr assay) and anti-HS reactivity (ELISA). We confirmed that SLE patients during renal exacerbations have a significantly higher anti-HS reactivity than patients without nephritis (P < 0.003). In addition, patients with nephritis also had higher titres of anti-DNA antibodies during renal exacerbations than during non-renal exacerbations (P < 0.01). A correlation between anti-DNA and anti-HS reactivity was observed (r = 0.40, P < 0.02), which in itself explains the correlation between nephritis and anti-HS reactivity. Comparing sera from nephritis and non-nephritis patients matched for anti-DNA titre, we found no difference in anti-HS reactivity, and therefore must conclude that the anti-HS reactivity is a direct reflection of anti-DNA reactivity.

Full text

PDF
55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brinkman K., Termaat R. M., de Jong J., van den Brink H. G., Berden J. H., Smeenk R. J. Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes. Res Immunol. 1989 Jun-Aug;140(5-6):595–612. doi: 10.1016/0923-2494(89)90122-3. [DOI] [PubMed] [Google Scholar]
  2. Brinkman K., Termaat R., Berden J. H., Smeenk R. J. Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol Today. 1990 Jul;11(7):232–234. doi: 10.1016/0167-5699(90)90095-q. [DOI] [PubMed] [Google Scholar]
  3. Brinkman K., Termaat R., Van den Brink H., Berden J., Smeenk R. The specificity of the anti-dsDNA ELISA. A closer look. J Immunol Methods. 1991 May 17;139(1):91–100. doi: 10.1016/0022-1759(91)90355-j. [DOI] [PubMed] [Google Scholar]
  4. Burlingame R. W., Rubin R. L., Balderas R. S., Theofilopoulos A. N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest. 1993 Apr;91(4):1687–1696. doi: 10.1172/JCI116378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Couser W. G., Salant D. J. In situ immune complex formation and glomerular injury. Kidney Int. 1980 Jan;17(1):1–13. doi: 10.1038/ki.1980.1. [DOI] [PubMed] [Google Scholar]
  6. Esparza R. H., Swaak T., Aarden L., Smeenk R. Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal. J Rheumatol. 1985 Dec;12(6):1109–1117. [PubMed] [Google Scholar]
  7. Faaber P., Rijke T. P., van de Putte L. B., Capel P. J., Berden J. H. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest. 1986 Jun;77(6):1824–1830. doi: 10.1172/JCI112508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fournié G. J. Circulating DNA and lupus nephritis. Kidney Int. 1988 Feb;33(2):487–497. doi: 10.1038/ki.1988.25. [DOI] [PubMed] [Google Scholar]
  9. Hylkema M. N., Huygen H., Kramers C., vd Wal T. J., de Jong J., van Bruggen M. C., Swaak A. J., Berden J. H., Smeenk R. J. Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J Immunol Methods. 1994 Mar 29;170(1):93–102. doi: 10.1016/0022-1759(94)90249-6. [DOI] [PubMed] [Google Scholar]
  10. Hylkema M. N., Kramers C., Van der Wal T. J., Van Bruggen M. C., Swaak A. J., Berden J. H., Smeenk R. J. A new ELISA for the detection of anti-heparan sulfate reactivity, using photobiotinylated antigen. J Immunol Methods. 1994 Nov 10;176(1):33–43. doi: 10.1016/0022-1759(94)90348-4. [DOI] [PubMed] [Google Scholar]
  11. Izui S., Lambert P. H., Miescher P. A. In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus. J Exp Med. 1976 Aug 1;144(2):428–443. doi: 10.1084/jem.144.2.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Koffler D., Agnello V., Thoburn R., Kunkel H. G. Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med. 1971 Sep 1;134(3 Pt 2):169s–179s. [PubMed] [Google Scholar]
  13. Kramers C., Hylkema M. N., van Bruggen M. C., van de Lagemaat R., Dijkman H. B., Assmann K. J., Smeenk R. J., Berden J. H. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest. 1994 Aug;94(2):568–577. doi: 10.1172/JCI117371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kramers C., Termaat R. M., ter Borg E. J., van Bruggen M. C., Kallenberg C. G., Berden J. H. Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis. Clin Exp Immunol. 1993 Jul;93(1):34–38. doi: 10.1111/j.1365-2249.1993.tb06493.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kramers K., Hylkema M., Termaat R. M., Brinkman K., Smeenk R., Berden J. Histones in lupus nephritis. Exp Nephrol. 1993 Jul-Aug;1(4):224–228. [PubMed] [Google Scholar]
  16. Madaio M. P., Carlson J., Cataldo J., Ucci A., Migliorini P., Pankewycz O. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol. 1987 May 1;138(9):2883–2889. [PubMed] [Google Scholar]
  17. Mannik M., Gauthier V. J., Stapleton S. A., Agodoa L. Y. Immune complexes with cationic antibodies deposit in glomeruli more effectively than cationic antibodies alone. J Immunol. 1987 Jun 15;138(12):4209–4217. [PubMed] [Google Scholar]
  18. Naparstek Y., Ben-Yehuda A., Madaio M. P., Bar-Tana R., Schuger L., Pizov G., Neeman Z. V., Cohen I. R. Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum. 1990 Oct;33(10):1554–1559. doi: 10.1002/art.1780331013. [DOI] [PubMed] [Google Scholar]
  19. Raz E., Brezis M., Rosenmann E., Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol. 1989 May 1;142(9):3076–3082. [PubMed] [Google Scholar]
  20. Rumore P. M., Steinman C. R. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest. 1990 Jul;86(1):69–74. doi: 10.1172/JCI114716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sasaki T., Hatakeyama A., Shibata S., Osaki H., Suzuki M., Horie K., Kitagawa Y., Yoshinaga K. Heterogeneity of immune complex-derived anti-DNA antibodies associated with lupus nephritis. Kidney Int. 1991 Apr;39(4):746–753. doi: 10.1038/ki.1991.91. [DOI] [PubMed] [Google Scholar]
  22. Schmiedeke T. M., Stöckl F. W., Weber R., Sugisaki Y., Batsford S. R., Vogt A. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med. 1989 Jun 1;169(6):1879–1894. doi: 10.1084/jem.169.6.1879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Smeenk R. J., Brinkman K., van den Brink H. G., Westgeest A. A. Reaction patterns of monoclonal antibodies to DNA. J Immunol. 1988 Jun 1;140(11):3786–3792. [PubMed] [Google Scholar]
  24. Smeenk R. J., Lucassen W. A., Swaak T. J. Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum. 1987 Jun;30(6):607–617. doi: 10.1002/art.1780300602. [DOI] [PubMed] [Google Scholar]
  25. Smeenk R., Hylkema M. Detection of antibodies to DNA: a technical assessment. Mol Biol Rep. 1992 Nov;17(1):71–79. doi: 10.1007/BF01006401. [DOI] [PubMed] [Google Scholar]
  26. Suenaga R., Abdou N. I. Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis. Clin Exp Immunol. 1993 Dec;94(3):418–422. doi: 10.1111/j.1365-2249.1993.tb08211.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Suzuki N., Harada T., Mizushima Y., Sakane T. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol. 1993 Jul 15;151(2):1128–1136. [PubMed] [Google Scholar]
  28. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  29. Termaat R. M., Assmann K. J., Dijkman H. B., van Gompel F., Smeenk R. J., Berden J. H. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int. 1992 Dec;42(6):1363–1371. doi: 10.1038/ki.1992.428. [DOI] [PubMed] [Google Scholar]
  30. Termaat R. M., Brinkman K., Nossent J. C., Swaak A. J., Smeenk R. J., Berden J. H. Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations. Clin Exp Immunol. 1990 Nov;82(2):268–274. doi: 10.1111/j.1365-2249.1990.tb05438.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Termaat R. M., Brinkman K., van Gompel F., van den Heuvel L. P., Veerkamp J. H., Smeenk R. J., Berden J. H. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun. 1990 Oct;3(5):531–545. doi: 10.1016/s0896-8411(05)80019-8. [DOI] [PubMed] [Google Scholar]
  32. Wold R. T., Young F. E., Tan E. M., Farr R. S. Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science. 1968 Aug 23;161(3843):806–807. doi: 10.1126/science.161.3843.806. [DOI] [PubMed] [Google Scholar]
  33. van den Born J., van den Heuvel L. P., Bakker M. A., Veerkamp J. H., Assmann K. J., Weening J. J., Berden J. H. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int. 1993 Feb;43(2):454–463. doi: 10.1038/ki.1993.67. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES